Quick Menu

Upcoming Journals

International Journal of Biochemistry Research & Review

International Journal of Biochemistry Research & Review, ISSN: 2231-086X,Vol.: 10, Issue.: 1

Original-research-article

Optimizing the Aggregation Propensity of Therapeutic Monoclonal Antibodies against Cancer and Autoimmune Diseases: A Computational Study

 

Anna-Isavella G. Rerra1†, Vasiliki P. Grimanelli1†, Nikos C. Papandreou1 and Stavros J. Hamodrakas1*
1Department of Cell Biology and Biophysics, Faculty of Biology, University of Athens, Panepistimiopolis, Athens 157 01, Greece.

 

Article Information
Editor(s):
(1) Rosario Gomez Garcia, Department of Biochemistry, Loyola University, USA.
Reviewers:
(1) Wei-Gang Hu, Defence Research and Development Canada, Canada.
(2) Wagner Loyola, Brazilian Agricultural Research Corporation, Brazil.
(3) Mona Samir Hashem Mahmoud, National Research Centre, Egypt.
(4) Chia-Li Yu, National Taiwan University Hospital, Taipei, Taiwan.
(5) Benjamin Pineda, National Institute of Neurology and Neurosurgery, Mexico.
Complete Peer review History: http://sciencedomain.org/review-history/12974

 

Abstracts

 

Monoclonal antibodies (mAbs) represent the most promising and rapidly growing class of therapeutic compounds for treating a wide variety of human chronic and acute diseases.  Despite their benefits, a major drawback in the exploitation of antibodies is their tendency to form aggregates.  As a result, severe immunological reactions in patients have been recorded.

In this study, we investigated the susceptibility of a set of therapeutic monoclonal antibodies to form aggregates. We selected antibodies that have all been approved by the U. S. Food and Drug Administration and are indicated for the treatment of various types of cancer and autoimmune diseases. The AMYLPRED 2 consensus method was used to predict ‘aggregation-prone’ regions on the surface of these proteins.

These regions are conserved and observed in almost all monoclonal antibodies commercially available. Considering the amino acid sequences of these antibodies, common groups of ‘aggregation-prone’ regions were identified, called clusters. We successfully reduced or even fully eliminated ‘aggregation-prone’ groups (clusters) by specific ‘mutations’ of the amino acids with exposed side chains. This information may be useful in future studies of monoclonal antibodies by improving existing therapeutic products or by designing novel ones.

 

Keywords :

Aggregation-prone regions; monoclonal antibodies; aggregation propensity; cancer; autoimmune diseases.

 

Full Article - PDF    Page 1-15    Article Metrics

 

DOI : 10.9734/IJBCRR/2016/23216

Review History    Comments

Search this site

Advanced Search

Announcement & News

ISI Thomson Reuters selected British Journal of Pharmaceutical Research for Emerging Sources Citation Index

We are delighted to inform that ISI Thomson Reuters selected British Journal of Pharmaceutical Resea...

SCOPUS selected Annual Research & Review in Biology (ARRB)

We are delighted to inform that famous indexing organization SCOPUS (from Elsevier) selected  A...

Index Copernicus Evaluation Result Released

We are delighted to inform that Index Copernicus (a leading indexing organization from Pol...

Journal Repository (JR): Permanent Digital Archiving of SDI journals

SDI is happy to announce that all our journals are now permanently archived in Journal Repository (J...

SDI journal got 35th ranking in Publons

We are delighted to announce (as of 04/01/2016) that British Journal of Medicine and Medical Re...

Growth of SDI and world publication market

As of 2014, total 25,064 journals are competing in World market of journal publication. In 2011, tot...

Science (IF: 31) report confirmed the high standard of SDI journal

As per a recent report (Link) of Science journal (present Impact factor 31), one of our journal (Bri...

SDI introduced Post-publication peer review by its comment section

SDI journals encourage Post-publication peer review by its comment section   Policy details a...

SDI promotes transparent Advanced OPEN peer review

We have migrated to transparent and toughest ‘Advanced OPEN peer review’ system (...



SCIENCEDOMAIN Awards

  • No Awards listed.

Browser Compatibility : Mozila firefox, Google Crome and IE 7 & above. Creative Commons License Terms & Condition   |   Privacy Policy   |   Join Us   |   Help   |   Contact Us
© Copyright 2010-2018, SCIENCEDOMAIN international. All rights reserved.